IL-13 as a novel growth factor in CTCL
MA Wasik - Blood, The Journal of the American Society of …, 2015 - ashpublications.org
MA Wasik
Blood, The Journal of the American Society of Hematology, 2015•ashpublications.orgIL-13 as a novel growth factor in CTCL | Blood | American Society of Hematology Skip to Main
Content Advertisement Umbrella Alt Text Umbrella Alt Text Close ASH Clinical News ASH
News Daily ASH-SAP Blood Journals Blood Blood Advances Blood Neoplasia Blood Vessels,
Thrombosis & Hemostasis Hematology The Hematologist International Blood Chinese
Edition Blood Japanese Edition Blood Italian Edition Blood Latin America Edition Blood
Spanish Edition ASH ASH Home Research Education Advocacy Meetings Publications ASH …
Content Advertisement Umbrella Alt Text Umbrella Alt Text Close ASH Clinical News ASH
News Daily ASH-SAP Blood Journals Blood Blood Advances Blood Neoplasia Blood Vessels,
Thrombosis & Hemostasis Hematology The Hematologist International Blood Chinese
Edition Blood Japanese Edition Blood Italian Edition Blood Latin America Edition Blood
Spanish Edition ASH ASH Home Research Education Advocacy Meetings Publications ASH …
In this issue of Blood, Geskin et al report that interleukin-13 (IL-13) acts as an autocrine growth factor in cutaneous T-cell lymphoma (CTCL) and that simultaneous antibody-based neutralization of IL-13 and IL-4 inhibits in vitro proliferation of CTCL cells. 1
ashpublications.org
